Latest Posts



Jun 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More


Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Implementing data efficiencies through AI-powered dashboards

Traditional drug discovery measures stand at the forefront of change with the developments that the pharmaceutical industry’s collaboration with technology has brought in. Several challenges in data collection, handling, and sharing are improved processes through new tools that focus on accelerating the drug development cycle with accurate, almost real-time data.

The drug development process includes many steps and challenges. These include challenges such as discovering unmet needs, designing optimal trials, keeping informed about competitors, as well as the regular reviewing of treatment guidelines and regulatory updates, but the amount of scientific and medical data creates the biggest challenge. Scientists and researchers spend hours in data accumulation and analysis. Due to the time-consuming nature of this process, there is a good chance that while one review or study is being annotated, another more recent and important one is missed out.

Manual methods of data collection and analysis are becoming obsolete. Technological developments have introduced advanced tools which offer almost real-time, up-to-date data and alerts users when new, relevant studies are published. These tools employ artificial intelligence technologies such as deep learning and neural networks to ensure data aggregation and tagging for accurate search queries. Traditionally, the medical affairs team, commercial team, and clinical team would go through the same paper to get insights relevant to each of them. However, AI-powered tools can analyze and provide relevant information to different teams through separate dashboards.

Innoplexus offers such dashboards through its product Ontosight. Ontosight enables data accumulation in almost real time, and drives efficient aggregation and analysis to ensure that relevant and useful information and insights are generated. This is achieved through graphs, and charts, that offer faster and better visualization of complex data. Time reduced in assimilating data can allow researchers to focus on strategic decisions and high-cognitive tasks.

Following are six dashboards offered by Innoplexus to pharmaceutical and biotechnology customers:

Medical Affairs Dashboard

Ontosight Medical Affairs Dashboard benefits researchers by keeping them up-to-date for timely decision-making. Based on the user’s interest, Ontosight Medical Affairs Dashboard provides cleaned and categorized information around clinical trials, treatment guidelines and label revisions for drugs via easy to understand visual graphics. This Medical affairs dashboard leverages information from various trial registries, major regulatory bodies, and scientific societies across the globe. Users can access individual clinical trials, treatment guidelines, or label changes through deep dive options.

Regulatory Updates Dashboard

Ontosight Regulatory Updates Dashboard provides its users information regarding the latest regulatory updates from major regulatory bodies such as FDA, and EMA at a glance, which is beneficial for regulatory affairs specialists in developing and executing a regulatory strategy for drug development. This dashboard empowers Therapeutic Business Unit Heads and CXOs to stay up-to-date with the latest pharmaceutical legal and regulatory changes, as well as real-time news and events specific to the indications of interest. Moreover, it also enables medical teams to make informed decisions through providing real-time information regarding relevant therapeutic guidelines from verified societies and target specific drug launches with the deep dive option into any drug.

Sentiment Analysis Dashboard

Ontosight Sentiment Analysis Dashboard offers intuitive, simplified drug performance monitoring through AI-powered labelling and analysis of sentiments around drugs. The dashboard can enable tracking of the competitive share of voice across drugs and indications of interest, and stay abreast of real-time buzz on sponsors, sentiment momentum, hot topics, and weak signals. It can also help improve the positioning of drugs through a quick analysis of patients’ and physicians’ sentiments from digital and scientific media across various channels and geographies, while identifying the top channels for the highest impact to derive targeted communication strategies. This leads to enhanced messaging and positioning of drugs through insights about customers and physicians perception by deriving targeted communication strategies

Treatment Guidelines Dashboard

Ontosight Guidelines Dashboard offers the pharmaceutical and biotechnology companies insights on guidelines around indications. It enables the identification of top guideline authors and notifies on indication-specific news to help drive successful utilization of drugs. The intuitive guideline monitor enables real-time trend analysis for latest & relevant guidelines. The dashboard also allows comparison of guidelines from different societies to quickly identify differences and similarities as well as to stay updated with comparative insights among guidelines for the indication of interest. Moreover, the dashboard can be leveraged for the identification of top guideline authors and key opinion leaders.

Competitive Intelligence Landscape Dashboard

Ontosight Discover Competitive Intelligence Landscape Dashboard is a dynamic and interactive tool that leverages artificial intelligence in order to provide real-time intelligence on competitors across the development and commercialization functions. This is attained through ontology driven detailed analysis of publications, clinical trials, related drugs and their development status, associated diseases, regulatory approval, and patents. Through aggregation and intuitive visualization of competitive intelligence across multiple sources, this dashboard is time-saving and assists pharmaceutical and biotechnology companies to stay ahead of their competitors.

Customized “My Dashboard”

Ontosight My Dashboard offers a customized approach to getting updates and insights of one’s choice. The dashboard generates an overview of insights from different business functions such as clinical, commercial, regulatory, and competitor intelligence to come up with the best marketing strategy. Innoplexus’s AI-enabled, intuitive solution to generate insights on topics of interest allows users to select data points and generate widgets in order to analyze data. These customized dashboards empower users to generate continuous AI-enabled insights, providing the latest and most relevant information for effective decision making. Users can get notified with timely updates using this dashboard and can reduce repetitive tasks through AI-powered aggregation and intuitive visualization.

For more information on Innoplexus’ AI-powered solutions, contact us.

Featured Blogs